Sarissa Capital Management LP's Net Worth
$385 Million
Who is Sarissa Capital Management LP?
Sarissa Capital Management LP has an estimated net worth of $385 Million. This is based on reported shares across multiple companies, which include APRICUS BIOSCIENCES, INC., VIVUS INC, IRONWOOD PHARMACEUTICALS INC, Sarissa Capital Acquisition Corp., Iterum Therapeutics plc, Regulus Therapeutics Inc., and Innoviva, Inc..
SEC CIK
Sarissa Capital Management LP's CIK is 0001577524
Past Insider Trading and Trends
2023 was Sarissa Capital Management LP's most active year for acquiring shares with 16 total transactions. Sarissa Capital Management LP's most active month to acquire stocks was the month of February. 2021 was Sarissa Capital Management LP's most active year for disposing of shares, totalling 3 transactions. Sarissa Capital Management LP's most active month to dispose stocks was the month of January. 2016 saw Sarissa Capital Management LP paying a total of $7,000,001.36 for 11,931,820 shares, this is the most they've acquired in one year. In 2021 Sarissa Capital Management LP cashed out on 35,619,949 shares for a total of $50,007,284.23, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IRONWOOD PHARMACEUTICALS INC (IRWD) Snapshot price: $14.91
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.38% | 1.66K |
—
|
—
| 121.94K |
Mar 15
| |||
Form 4
| +1.13% | 1.35K |
—
|
—
| 120.28K |
Dec 15
| |||
Form 4
| +1.54% | 1.8K |
—
|
—
| 118.93K |
Sep 15
| |||
Form 4
| +23.58% | 22.35K |
—
|
—
| 117.13K |
Jun 20
| |||
Form 4
| +1.45% | 1.36K |
—
|
—
| 94.78K |
Jun 15
| |||
Form 4
| +1.56% | 1.44K |
—
|
—
| 93.42K |
Mar 15
| |||
Form 4
| +1.37% | 1.24K |
—
|
—
| 91.98K |
Dec 15
| |||
Form 4
| +1.54% | 1.37K |
—
|
—
| 90.74K |
Sep 15
| |||
Form 4
| +1.39% | 1.22K |
—
|
—
| 89.37K |
Jun 15
| |||
Form 4
| +32.40% | 21.57K |
—
|
—
| 88.14K |
Jun 1
| |||
Form 4
| +1.76% | 1.15K |
—
|
—
| 66.57K |
Mar 15
| |||
Form 4
| +1.89% | 1.21K |
—
|
—
| 65.42K |
Dec 15
| |||
Form 4
| +1.80% | 1.14K |
—
|
—
| 64.21K |
Sep 15
| |||
Form 4
| +1.99% | 1.23K |
—
|
—
| 63.07K |
Jun 15
| |||
Form 4
| +58.26% | 22.77K |
—
|
—
| 61.84K |
Jun 2
| |||
Form 4
| +3.26% | 1.24K |
—
|
—
| 39.08K |
Mar 15
| |||
Form 4
| +1.39% | 225K |
$10.38 | $2,335,500.00 | 16.39M |
Mar 8 - Mar 10
| |||
Form 4
| +5.04% | 775K |
$10.01 | $7,758,750.00 | 16.16M |
Mar 3 - Mar 5
| |||
No matching records found |
Sarissa Capital Acquisition Corp. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Iterum Therapeutics plc (ITRM) Snapshot price: $1.7299
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$2.43 | -$50,007,284.23 | 20.62M |
Feb 11 - Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
APRICUS BIOSCIENCES, INC. (SEEL) Snapshot price: $0.7365
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 4
| +0.42% | 6.1K |
$1.63 | $9,949.52 | 1.45M |
Aug 31
| |||
Form 4
| +84.89% | 6.65M |
$0.88 | $5,850,000.64 | 14.48M |
Mar 3
| |||
Form 4
| +20.03% | 1.31M |
$0.88 | $1,150,000.72 | 7.83M |
Jan 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Regulus Therapeutics Inc. (RGLS) Snapshot price: $1.3612
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |